CDC

Estimates from the CDC indicate a new Omicron subvariant is becoming prevalent in the US. Dubbed BA.2.12.1, it is likely to be the most infectious version of SARS-CoV-2 to date and experts warn it could be triggering a new wave of cases in the country.

A report from the CDC has found COVID-19 was the third leading cause of death in the US in 2021, after heart disease and cancer. Another new CDC report estimates nearly 60 percent of the US population had been infected with SARS-CoV-2 by February 2022.

Researchers are reporting the case of a healthcare worker testing positive to COVID-19 twice in 20 days. Genomics revealed the first infection was Delta and the second Omicron, making this the shortest recorded gap between two SARS-CoV-2 infections.

New CDC modeling estimates the BA.2 Omicron variant is now dominant in the United States. In related news the FDA has withdrawn its emergency authorization for the COVID-19 antibody treatment sotrovimab as research has found it ineffective against BA.2.

The FDA has authorized a fourth mRNA vaccine dose for all individuals aged 50 and over. The authorization includes both Pfizer and Moderna vaccines and is recommended to be administered at least four months after a third dose.

Delta-8 THC is similar to its commonly known psychoactive cousin, delta-9 THC, and new studies are offering the first large-scale insights into what kinds of effects people are experiencing with this unique and under-researched drug.

A report from the CDC indicates disease caused by Omicron may be less severe than prior variants, but increased transmissibility means the US is facing the heaviest load on its hospitals seen since the pandemic began two years ago.

A trio of CDC studies offer the first real-world insights into the effectiveness of a third COVID-19 vaccine dose against the Omicron variant. The research confirms a third vaccine dose restores protection from infection and hospitalization.

A report from the CDC has found children who have recovered from COVID-19 infection are more likely to develop diabetes than those with no history of infection. The researchers call for more study into the association between COVID-19 and diabetes.

A new report from the Centers for Disease Control and Prevention indicates the Omicron variant is now dominant in the United States. The CDC’s variant-tracking model found Omicron has skyrocketed in prevalence over the course of two to three weeks.

New data from the Centers for Disease Control and Prevention (CDC) indicate the Omicron variant is rapidly increasing in prevalence in the United States, accounting for nearly three percent of all cases sequenced in the country over the past week.

US regulators have authorized a 3rd COVID-19 vaccine booster for adults over age 18. The recommendations simplify the health advice and infectious disease expert Anthony Fauci urges boosters for all those who are six months beyond their second dose.